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channels. None of them showed signi cant modulation, suggesting 
that channel activity, rather than expression level, is affected in 
this model.
MR activation speci cally in endothelial cells is therefore associated 
with increased BP and altered vascular reactivity, in absence of 
renal collecting duct mediated MR effects. This may be related to 
ion channels remodeling.
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Mutations at the WNK1 gene cause Gordon syndrome, a rare 
inherited form of arterial hypertension. The gene encodes a short 
kidney-speci c isoform and a complete long isoform, L-WNK1, 
expressed ubiquitously and notably within the vascular system.
Objective — The aim of our study was to investigate the vascular 
role of L-WNK1 in mice.
Method — We used mice bearing a constitutive homozygous 
inactivation of L-WNK1 (L-WNK1-/-) which die in utero before day 
13 of gestation as well as adult healthy heterozygous (L-WNK1+/-) 
and wild-type (L-WNK1+/+) littermates. We isolated vessels from 
L-WNK1+/- and L-WNK1+/+ to perform in vitro pharmacological 
studies in a wire-myograph system and an arteriograph system.
Results — We  rst showed that L-WNK1-/- embryos present growth 
retardation and severe oedema. An abnormal vascular remodeling 
was observed at day 10.5 within the primary vascular network 
of L-WNK1-/- embryos as well as in the yolk sac, suggesting an 
important role of L-WNK1 in cardiovascular development. We next 
showed that vascular diameters of pressurized arteries as well 
as arterial blood  ow velocities measured by echo-Doppler were 
comparable between L-WNK1+/- and L-WNK1+/+ mice. Endothelium-
dependent dilatations induced either by acetylcholine or by  ow 
were also comparable between both groups of mice. In contrast, 
phenylephrine-induced vasoconstrictions were signi cantly reduced 
in L-WNK1+/- mice compared to L-WNK1+/+ mice in thoracic aorta 
as well as in mesenteric arteries (27.45 % (P=0.04) and 39.6 % 
(P=0.0015) decrease at maximal concentration, respectively) 
whereas potassium chloride contractions remained comparable. 
Furthermore, myogenic tone in L-WNK1+/- mesenteric arteries 
was also signi cantly blunted when compared to L-WNK1+/+ mice 
(P<0.0001).
Conclusions — Our results evidenced for the  rst time a vascular 
role for L-WNK1 in pressure- and agonist- induced contractions.
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Serum Response Factor (SRF) has emerged as a dispensable 
transcription factor for cellular growth but an absolutely essential 
orchestrator of actin cytoskeleton and contractile homeostasis. 
SRF is a founding member of MADS domain-containing family of 
transcription factors and is present in most, if not all, species from 
animals to plants and fungus kingdoms. Signaling to SRF occurs 
principally through mitogen-activated protein kinase (MAPK) or RhoA 
pathways that converge on the nucleus to stimulate gene expression. 
In the microcirculation, diameter adjustments in response to change 
in intraluminal pressure or  ow mainly depend on the integrity of 
the vascular cytoskeleton. We thus hypothesised that the deletion 
in SRF will affect the mechanotransduction in resistance arteries. 
To address the role of SRF, the tail caudal and mesenteric arteries 
from inducible SRF KO mice and their littermate control were 
mounted in an arteriograph. Contraction to stepwise increase in 
pressure (myogenic tone) and relaxation to progressive increases 
in intraluminal  ow were determined in each group. The protein 
and gene expressions were quanti cated by western blot and qPCR. 
SRF de ciency reduced myogenic tone in tail arteries (CT:16.3±3.2 % 
of Passive Diameter (PD) versus KO:5.9±2.3 % PD ; P<0.05) and in 
mesenteric arteries (CT:26±2.3 % PD versus KO:11±1.8 % PD ; P<0.05). 
No effect was observed on the  ow mediated dilation and receptor 
dependant contraction induced by Phenylephrine, Angiotensine II 
and U46619. SRF alteration induced modi cations of contraction 
signalling pathways as p38 MAP kinase, Myosin Light Chain Kinase, 
Myosin Light Chain, Src, Caveolin 1 or cytoskeleton proteins. 
Furthermore, actin polymerisation was also spoiled. This study 
reported for the  rst time that the SRF inhibition with an inducible 
KO signi cantly affected speci cally the myogenic tone. This 
suggests that SRF is involved in the pressure mechanotransduction 
in resistance arteries. Due to the central role of myogenic tone in 
vascular disorders and organs autoregulation this  nding opens new 
perspectives in the pathophysiology of the microcirculation and 
provides new therapeutic targets.
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Epac (Exchange protein directly activated by cAMP), a guanine 
exchange factor (GEF) for the Ras-like GTPases Rap, has been 
identi ed as a novel cAMP sensor, alongside of PKA. We have 
previously shown that Epac activation, through β-adrenergic 
receptor stimulation, induces cardiomyocyte hypertrophy (Morel 
et al, 2005, Metrich et al, 2008).
This work was intended to identify the component of the Epac 
signaling cascade leading to cardiac hypertrophy and in particular 
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the implication of the Epac—induced small G proteins and theirs 
networks.
In cardiomyocyte primary culture, we show that Epac activates the 
small G protein Ras, Rac and Rap. The Epac-induced hypertrophic 
effect is mediated by Ras and Rac activation. This Epac-induced 
activation of Ras is not in uenced by Rac or Rap and is due to 
a Ca2+ release in response to phospholipase C and IP3 receptor 
activation. Moreover, we show that Ras mediates the Epac-induced 
activation of the pro-hypertrophic CaMKII/MEF2 and calcineurin/
NFAT signalling pathways which are both necessary for hypertrophy. 
Epac has been initially identi ed as a GEF for the small G proteins 
Rap. Surprisingly, the Epac hypertrophic effect is independent 
of its classical effector Rap. The Epac-induced Rap1 signalling 
cascade involves PKCε translocation, which is a key actor of 
multiple cellular phosphorylations. This  nding is in agreement 
with other Rap functions reported in the literature such as cell to 
cell communication and adhesion.
Altogether, these data present new insights into the Epac signaling 
network with both pro-hypertrophic and non-hypertrophic effects.
- Morel E, Marcantoni A, Gastineau M, Birkedal R, Rochais F, 
Garnier A, Lompré AM, Vandecasteele G, Lezoualc’h F. cAMP-
binding protein Epac induces cardiomyocyte hypertrophy. Circ Res. 
97 : 1296-304, 2005
- Métrich M, Lucas A, Gastineau M, Samuel JL, Heymes C, Morel 
E, Lezoualc’h F.
Epac mediates beta-adrenergic receptor-induced cardiomyocyte 
hypertrophy. Circ Res. 102 : 959-65, 2008
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In mouse models the genetic deletion of TWIK-related acid-sensitive 
K (TASK)-1 and TASK-3 channels removes an important background 
K current that results in a marked depolarization of adrenal zona 
glomerulosa cell membrane potential, leading to the autonomous 
overproduction of aldosterone. The importance of TASK channel 
dysfunction in human primary aldosteronism (PAL) however, is 
uncertain, motivating their molecular analysis. We screened coding 
exons and  anking intronic sequences of KCNK3 and KCNK9 (genes 
coding for TASK 1 and TASK 3 respectively) in 825 PAL patients for 
germline DNA sequence variants. A total of 14 different coding 
sequence variants were found in 19 patients. The variants include 8 
different synonymous mutations and 6 different missense variants. 
In silico predictions (PolyPhen, SIFT and Alamut) suggested the 
non-synonymous mutations to be potentially damaging. Analysis 
of mutated channel function by heterologous expression, however, 
revealed the missense mutations detected were non-functional. 
As somatic mutations may be involved in some cases of sporadic 
PAL, sequencing 90 patients for tumoral DNA sequence variants is 
underway. We are also investigating expression of TASK 1 and TASK 
3 by in-situ hybridization and immunohistochemistry on adrenal 
tissue sections of 150 PAL patients who have undergone surgery.
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Background — Although estrogen administration to hysterectomized 
menopausal women did not prevent the occurence of myocardial 
infarction in a randomized controlled trial (WHI 2004), 
epidemiological studies suggest and experimental results clearly 
demonstrate a major atheroprotective action of estrogens. The 
goal of the present study was to identify the cellular target(s) 
accounting for the estradiol (E2) bene cial action on fatty streak 
development.
Methods and Results — We  rst con rmed the key role of estrogen 
receptor α (ERα) in atheroprotective effect of E2 as this action 
was completely abolished in mice de cient both in Low Density 
Lipoprotein receptor (LDLr) and in ERα. Comparison of LDLr-
/- mice transplanted with either ERα+/+ or ERα-/- bone marrow 
showed that functional ERα in the hematopoietic lineage is not 
required for E2 atheroprotection. We then showed that ERα  oxed 
mice (ERα ox/ ox) bred with the Tie2-Cre mice on the LDLr-
/- background had a complete inactivation of ERα both in bone 
marrow and in endothelial cells. Remarkably, in this mouse model, 
the E2 atheroprotective action was completely abolished.
Conclusions — Altogether, this is the  rst in vivo demonstration that 
endothelial ERα represents a key target of the atheroprotective 
effect of E2, whereas the hematopoietic ERα is dispensable for 
the protective action. Selective estrogen receptor modulators that 
mimic this endothelial action of E2 should now be considered in 
hormonal treatment as well as in atheroprotection.
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Introduction — Le SRA est impliqué dans l’homéostasie hydrosodée 
et la régulation de la pression artérielle (PA). L’objectif du projet 
Saphir (Thomas et al., Phil Trans R Soc A, 2008) est le développement 
d’un modèle multiniveaux du système cardiovasculaire rénal (CVR). 
Nous présentons ici la modélisation du SRA circulant, intégré au 
modèle circulatoire de Guyton.
Modelisation — Le modèle est implémenté sous Simulink© 
(Mathworks). Hypothèses : (i) la rénine est produite par l’appareil 
juxtaglomérulaire (JGA) et l’artériole afférente ; (ii) la production 
de rénine est inhibée par la pression de perfusion, le signal TGF 
